Linguamatics

Linguamatics, a subsidiary of IQVIA founded in 2001, is a leading innovator in natural language processing (NLP) and machine translation technologies tailored for the healthcare and life sciences sectors. With headquarters in Cambridge, England, and offices in the US and UK, their solutions are utilized by 17 of the top 20 global pharmaceutical companies, the US FDA, and numerous healthcare providers. Linguamatics' technology simplifies complex scientific data, enabling efficient and scalable management of information for decision support and knowledge discovery.

Their platform integrates NLP, neural machine translation (NMT), and specialized AI models to extract insights from unstructured text, provide instant translations, and support global operations across clinical research, regulatory affairs, pharmacovigilance, and more. Linguamatics offers both software products and services, including healthcare-specific NLP, secure instant translation, a translation management platform, and specialized language services, aiding in tasks such as adverse event detection and social determinants of health analysis.

Highlights:

• Pioneer in healthcare-specific NLP and machine translation
• Serves 17 of the top 20 global pharmaceutical companies
• Secure instant translations across 150+ languages
• Centralized translation management platform
• Specialized language services for clinical trials and regulatory submissions

Key Features:

• Healthcare-specific NLP
• Secure instant translation
• Translation management platform
• Specialized language services
• AI-powered insights

Benefits:

• Accelerates global clinical trials
• Enhances pharmacovigilance automation
• Improves healthcare data mining
• Boosts multilingual patient engagement
• Reduces costs and time in global operations

Use Cases:

• Clinical trial globalization
• Pharmacovigilance automation
• Healthcare data mining
• Multilingual patient engagement
• Regulatory document translation